生技公司
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership2,722 shares
Latest Disclosed Value $ 599,000
Advisor Group, Inc. reports 23.78% increase in ownership of TECH / Bio-Techne Corporation

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 2,722 shares of Bio-Techne Corporation (US:TECH) valued at $149,377 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 2,199 shares of Bio-Techne Corporation. This represents a change in shares of 23.78% during the quarter. The current value of the position is $141,517 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F BIO TECHNE COM 09073M104 2,722 523 23.78 599 39.30 0.0041
2019-11-13 2019-09-30 13F BIO TECHNE COM 09073M104 2,199 -415 -15.88 430 -21.10 0.0032
2019-07-31 2019-06-30 13F BIO TECHNE COM 09073M104 2,614 -153 -5.53 545 -0.91 0.0042
2019-05-09 2019-03-31 13F BIO TECHNE COM 09073M104 2,767 942 51.62 550 107.55 0.0045
2019-02-11 2018-12-31 13F BIO TECHNE COM 09073M104 1,825 188 11.48 265 -20.66 0.0026
2018-11-14 2018-09-30 13F BIO TECHNE COM 09073M104 1,637 75 4.80 334 44.59 0.0034
2018-08-13 2018-06-30 13F BIO TECHNE COM 09073M104 1,562 -286 -15.48 231 -17.50 0.0032
2018-05-15 2018-03-31 13F BIO TECHNE COM 09073M104 1,848 560 43.48 280 67.66 0.0038
2018-02-14 2017-12-31 13F BIO TECHNE COM 09073M104 1,288 505 64.50 167 77.66 0.0022
2017-11-06 2017-09-30 13F BIO TECHNE COM 09073M104 783 97 14.14 94 17.50 0.0015
2017-11-03 2017-06-30 13F/A-1 BIO TECHNE COM 09073M104 686 84 13.95 80 31.15 0.0014
2017-08-11 2017-06-30 13F BIO TECHNE COM 09073M104 686 84 79
2017-11-02 2017-03-31 13F/A-1 BIO TECHNE COM 09073M104 602 101 20.16 61 17.31 0.0012
2017-05-15 2017-03-31 13F BIO TECHNE COM 09073M104 602 101 60
2017-11-02 2016-12-31 13F/A-1 BIO TECHNE COM 09073M104 501 33 7.05 52 1.96 0.0012
2017-01-31 2016-12-31 13F BIO TECHNE COM 09073M104 501 33 52
2017-11-02 2016-09-30 13F/A-1 BIO TECHNE COM 09073M104 468 195 71.43 51 70.00 0.0012
2016-11-08 2016-09-30 13F BIO TECHNE COM 09073M104 468 195 51
2016-08-11 2016-06-30 13F BIO TECHNE COM 09073M104 273 30
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.